Sun Pharma revenue rises 12% as specialty-drug sales grow

Sun Pharma’s quarterly revenue rose nearly 12% to Rs161.99bn, while specialty-drug sales grew 6.9% to $356m. A Rs12.69bn one-off charge linked largely to Organon cut reported profit.